Spinal Cord Injuries (SCI)NCT06777576
Self-balancing Personal Exoskeleton for SCI
A study testing Hands-free exoskeleton in people with Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, run by Wandercraft at 1 site in United States.
Trial summary
This study aims to demonstrate the safety and effectiveness of the Eve personal exoskeleton in individuals with spinal cord injury (SCI). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Spinal Cord Injuries (SCI), Paraplegia and Tetraplegia
- What is being tested?
- Hands-free exoskeleton
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 27 participants
- Where
- 1 siteUnited States
- Study dates
- 12 Feb 2025to 24 Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
SCI user inclusion Criteria:
- Any gender, age 18 years or older;
- Motor complete or incomplete SCI with lesions at or above T6;
- ≥ 6 months post SCI;
- Able and willing to attend 9 to 10 visits1 to the center, including sessions of training and assessments of one-to-three hours duration;
- Able to read, understand, and provide informed consent;
- Living in the US and speaks English.
SCI user exclusion Criteria:
- Diagnosis of neurological injury other than SCI;
- Progressive condition that would be expected to result in changing neurological status;
- Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician;
- Unhealed or unstable traumatic or high impact lower extremity fracture of any duration that is, in the clinical judgement of the study physician, exclusionary for standing and walking;
- Knee (proximal tibia and/or distal femur) BMD <0.60 gm/cm2;
- Total hip BMD T-scores < -3.5;
- Fragility, minimal trauma, or low impact fracture of the lower extremity since SCI;
- Untreatable severe spasticity judged to be contraindicated by the site physician;
- Untreated/uncontrolled hypertension, as judged to be contraindicated by the site physician;
- Unresolved orthostatic hypotension (change from baseline seated BP to a fall in 20mmHg SBP and/or fall in 10mmHG DBP and symptoms when standing), or as judged to be contraindicated by the site physician;
- Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton;
- Morphological contraindications to the use of the device;
- Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools;
- Unable to effectively operate the device with a hand-control interface, due to functional and/or cognitive impairment, evaluated based on the ability to manipulate the joystick in all direction, press and identify buttons on the hand control interface.
- Improper fitting in the device;
- Psychopathology documentation in the medical record that may conflict with study objectives;
- Pregnancy or women who plan to become pregnant during the study period;
- Concurrent participation in another interventional trial;
- History of uncontrolled autonomic dysreflexia;
- Presence colostomy and/or urostomy;
- Ventilator use at the time of the exoskeleton use.
Companion inclusion Criteria:
- Any gender, age 18 years or older;
- Willingness to attend 9 to 10 visits to the center, including sessions of training and assessments of one-to-three hours duration with the SCI user;
- Able to read, understand and provide informed consent;
- Living in the US and speaks English.
Companion exclusion Criteria:
- Inability to communicate with an assistant due to cognitive and language disorders;
- Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol- specified assessments;
- Insufficient strength and performance capability, evidenced by the ability to hold and retain the device in case of unbalance/fall;
- Insufficient availability to complete the study;
- Concurrent participation in another interventional trial.
Trial locations and contacts
1 site in 1 country.
United States1 site
James J. Peters, VA Medical Center, Bronx, NY
The Bronx, New York, 10468-3904
About this study
Official title: Empowering Mobility in People With Spinal Cord Injury With a Hands-free, Self-balancing Personal Exoskeleton
This study aims to demonstrate the safety and effectiveness of the Eve personal exoskeleton in individuals with spinal cord injury (SCI).
Read the detailed description
This personal exoskeleton, developed by Wandercraft as a new version of the Atalante X, offers a novel hands-free and self-balancing design, aiming at enhancing stability and mobility for users in daily activities.
The study features an interventional, prospective, single-group, and open-label design, conducted over 3 to 4 weeks at two US research facilities. 24 subjects are required to complete the study. Anticipating a 15% dropout rate, the study will enroll 29 participants.
Over the course of nine to ten scheduled visits, participants undergo a sequence of procedures, beginning with screening and device fitting. This is followed by five training sessions which conclude with an evaluation to issue a competency certificate to confirm the ability to use the device across all its "basic skills". Additionally, two sessions are dedicated to evaluating the exoskeleton's effectiveness outcomes, complemented by an extra practice session. Each visit lasts an average of 1.5 hours.
- Being tested
- Hands-free exoskeleton
- Keywords
- Spinal Cord Injury, Robotics, Hands-free exoskeleton, Overground exoskeleton, Walking, Self-balancing, personal use, home
- Medical subject headings
- Spinal Cord Injuries, Paraplegia, Quadriplegia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hands-free exoskeletonDevice
A "device trainer specialist" from the investigation site will deliver training sessions with the exoskeleton to pair of participants (a pair corresponds to an individual with SCI and his/her companion). The device trainer will follow the progression of the pair through the training program and ensure they learn all the device "basic skills". Each training session lasts an average of 1.5 hours, variations according to the user's learning pace and tolerance. During the sessions with the exoskeleton, the participants will engage in mobility activities on different surfaces and perform Activities of Daily Living in simulated environments such as kitchen, bathroom, elevators and outdoor spaces.
| Study group | Role | What they receive |
|---|---|---|
| Hands-free exoskeleton | Experimental | Not described Receives: Device: Hands-free exoskeleton |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less.
The TUG evaluates the time from starting in a seated position to stand-up, walk 3 meters, turn around, walk back 3 meters and sit down on indoor surface.
Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT).
The 6MWT measures the distance in meters traversed over 6 min, on indoor surface.
Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Secondary outcomes (3)
Proportion of subjects who can complete at least 4 out of the 6 Activities of Daily Living (ADLs), in various simulated environments and with the exoskeleton.
The ADLs are done standing in front of the countertop in the kitchen, in a simulated living room, taking a 50m walk in the outdoor environment, taking the elevator, in the bathroom and walking in a hallway and through a door to get to the next room.
Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who complete the 10-Meter Walk Test (10MWT) on indoor surfaces in 1 minute or less.
The 10MWT measures the time in seconds taken to walk 10 meters.
Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who can don or doff the device within 10 minutes each, separately.
Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jan 2025
- Study start12 Feb 2025
- Primary completion10 Jun 2026
- Study completion24 Jun 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spinal Cord Injuries (SCI)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 27 participants (actual)
Sponsor and investigators
- Lead sponsor
- Wandercraft
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- James J. Peters Veterans Affairs Medical Center
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06777576
- Sponsor's protocol ID
- CIP007
- Status last verified
- Oct 2026
- First submitted
- 8 Jan 2025
- Last updated
- 15 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No: Individual Participant Data will not be shared.
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Empowering Mobility in People With Spinal Cord Injury With a Hands-free, Self-balancing Personal Exoskeleton
- ClinicalTrials.gov ID
- NCT06777576
- Acronym / sponsor ID
- CIP007
- Keywords
- Spinal Cord Injury, Robotics, Hands-free exoskeleton, Overground exoskeleton, Walking, Self-balancing, personal use, home
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 27 participants (actual)
- Lead sponsor
- WandercraftIndustry (pharma, biotech, devices)
- Collaborators
- James J. Peters Veterans Affairs Medical Center
- Study start
- 12 Feb 2025 (actual)
- Primary completion
- 10 Jun 2026 (actual)
- Study completion
- 24 Jun 2026 (actual)
- First posted
- 16 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to demonstrate the safety and effectiveness of the Eve personal exoskeleton in individuals with spinal cord injury (SCI).
Detailed description
This personal exoskeleton, developed by Wandercraft as a new version of the Atalante X, offers a novel hands-free and self-balancing design, aiming at enhancing stability and mobility for users in daily activities.
The study features an interventional, prospective, single-group, and open-label design, conducted over 3 to 4 weeks at two US research facilities. 24 subjects are required to complete the study. Anticipating a 15% dropout rate, the study will enroll 29 participants.
Over the course of nine to ten scheduled visits, participants undergo a sequence of procedures, beginning with screening and device fitting. This is followed by five training sessions which conclude with an evaluation to issue a competency certificate to confirm the ability to use the device across all its "basic skills". Additionally, two sessions are dedicated to evaluating the exoskeleton's effectiveness outcomes, complemented by an extra practice session. Each visit lasts an average of 1.5 hours.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Hands-free exoskeleton | Experimental | Device: Hands-free exoskeleton |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hands-free exoskeletonA "device trainer specialist" from the investigation site will deliver training sessions with the exoskeleton to pair of participants (a pair corresponds to an individual with SCI and his/her companion). The device trainer will follow the progression of the pair through the training program and ensure they learn all the device "basic skills". Each training session lasts an average of 1.5 hours, variations according to the user's learning pace and tolerance. During the sessions with the exoskeleton, the participants will engage in mobility activities on different surfaces and perform Activities of Daily Living in simulated environments such as kitchen, bathroom, elevators and outdoor spaces. | Device | Hands-free exoskeleton |
Primary outcome
Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
The TUG evaluates the time from starting in a seated position to stand-up, walk 3 meters, turn around, walk back 3 meters and sit down on indoor surface.
Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT).
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
The 6MWT measures the distance in meters traversed over 6 min, on indoor surface.
3 secondary outcomes
Proportion of subjects who can complete at least 4 out of the 6 Activities of Daily Living (ADLs), in various simulated environments and with the exoskeleton.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who complete the 10-Meter Walk Test (10MWT) on indoor surfaces in 1 minute or less.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who can don or doff the device within 10 minutes each, separately.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2026.
- Individual participant dataSharing planned: No. Individual Participant Data will not be shared.
Related trials for Spinal Cord Injuries (SCI)
Active, not recruitingObservational study
Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Spinal Cord Injury, Spinal Cord Injury at C5-C7 Level
Recruiting
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
Enrolling by invitation
AI-Guided Multi-Electrode Transcutaneous Spinal Cord Stimulation for Gait Rehabilitation in People With Spinal Cord Injury or Stroke
Spinal Cord Injuries (SCI)
Not yet recruiting
Functional Electrical Stimulation Plus High Intensity Interval Training at Home
Spinal Cord Injuries (SCI)
Recruiting
Physical Therapy Wound Care Modalities in Patients With Spinal Cord Injury (SCI)
Spinal Cord Injuries, Pressure Injuries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hands-free exoskeleton in people with Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, run by Wandercraft at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less. (time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.